1416 Results

People

  1. Motzer
    Motzer
  2. Vickers
    Vickers
  3. Hudis
    Hudis
  4. Norton
    Norton
  5. Saltz
    Saltz
  6. O'Reilly
    O'Reilly
  7. Mao
    Mao
  8. Morris
    Morris
  9. Seidman
    Seidman
  10. Kris
    Kris

Groups

  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)
  7. Hematologic Malignancies, Division of (169)
  8. Genitourinary Oncology Service (160)
  9. Center for Hematologic Malignancies (142)
  10. Gastrointestinal Oncology Service (126)
  1. "randomized controlled trial"
Formats
  1. Journal Article (1353)
  2. Review (19)
  3. Conference Paper (17)
  4. Editorial (9)
  5. Correspondence (5)
  6. Research Letter (5)
  7. Meeting Abstract (4)
  8. Guidelines (3)
  9. Book Section (1)
Groups
  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)

More Groups

People
  1. Robert Motzer (83)
  2. Andrew Vickers (48)
  3. Larry Norton (34)
  4. Clifford Hudis (33)
  5. Leonard Saltz (32)
  6. Eileen O'Reilly (25)

More People

Years
  1. 2025 (63)
  2. 2024 (165)
  3. 2023 (110)
  4. 2022 (81)
  5. 2021 (39)
  6. 2020 (51)

More Years

Publications
  1. Journal of Clinical Oncology (164)
  2. New England Journal of Medicine (65)
  3. Lancet Oncology (46)
  4. Cancer (42)
  5. Clinical Cancer Research (42)
  6. European Urology (26)

More Publications

Publishers
  1. Elsevier Inc. (187)
  2. American Society of Clinical Oncology (170)
  3. Elsevier Science, Inc. (138)
  4. Springer (79)
  5. Lippincott Williams & Wilkins (72)
  6. Wiley Blackwell (71)

More Publishers

Results (1416)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of nivolumab versus everolimus in advanced renal cell carcinoma (aRCC)
    Journal Article

    Shah, R.; Botteman, M.; Solem, C. T.; Luo, L.; Doan, J.; Cella, D.; Motzer, R. J.
    Clinical Genitourinary Cancer (2019)

    Fulltext@MSK | Save
  • Early MRI predictors of disease-free survival in locally advanced rectal cancer from the GRECCAR 4 trial
    Journal Article

    Nougaret, S.; Castan, F.; de Forges, H.; Vargas, H. A.; Gallix, B.; Gourgou, S.; Rouanet, P.; on behalf of the GRECCAR Study Group
    British Journal of Surgery (2019)

    Fulltext@MSK | Save
  • Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: Extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial
    Journal Article

    Motzer, R. J.; Rini, B. I.; McDermott, D. F.; Arén Frontera, O.; Hammers, H. J.; Carducci, M. A.; Salman, P.; Escudier, B.; Beuselinck, B.; Amin, A.; more...
    Lancet Oncology (2019)

    Fulltext@MSK | Save
  • PD-L1 expression and clinical outcomes to cabozantinib, everolimus, and sunitinib in patients with metastatic renal cell carcinoma: Analysis of the randomized clinical trials METEOR and CABOSUN
    Journal Article

    Flaifel, A.; Xie, W.; Braun, D. A.; Ficial, M.; Bakouny, Z.; Nassar, A. H.; Jennings, R. B.; Escudier, B.; George, D. J.; Motzer, R. J.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Health outcomes, utility and costs of returning incidental results from genomic sequencing in a Canadian cancer population: Protocol for a mixed-methods randomised controlled trial
    Journal Article

    Shickh, S.; Clausen, M.; Mighton, C.; Gutierrez Salazar, M.; Zakoor, K. R.; Kodida, R.; Reble, E.; Elser, C.; Eisen, A.; Panchal, S.; more...
    BMJ Open (2019)

    Fulltext@MSK | Save
  • Effect of tandem autologous stem cell transplant vs single transplant on event-free survival in patients with high-risk neuroblastoma: A randomized clinical trial
    Journal Article

    Park, J. R.; Kreissman, S. G.; London, W. B.; Naranjo, A.; Lerner Cohn, S.; Hogarty, M. D.; Tenney, S. C.; Haas-Kogan, D.; Shaw, P. J.; Kraveka, J. M.; more...
    JAMA - Journal of the American Medical Association (2019)

    Fulltext@MSK | Save
  • Ibrutinib-rituximab or chemoimmunotherapy for chronic lymphocytic leukemia
    Journal Article

    Shanafelt, T. D.; Wang, X. V.; Kay, N. E.; Hanson, C. A.; O'Brien, S.; Barrientos, J.; Jelinek, D. F.; Braggio, E.; Leis, J. F.; Zhang, C. C.; more...
    New England Journal of Medicine (2019)

    Fulltext@MSK | Save
  • A phase 2, randomized trial evaluating the combination of dalantercept plus axitinib in patients with advanced clear cell renal cell carcinoma
    Journal Article

    Voss, M. H.; Bhatt, R. S.; Vogelzang, N. J.; Fishman, M.; Alter, R. S.; Rini, B. I.; Beck, J. T.; Joshi, M.; Hauke, R.; Atkins, M. B.; more...
    Cancer (2019)

    Fulltext@MSK | Save
  • Efficacy of a web-based women’s health survivorship care plan for young breast cancer survivors: A randomized controlled trial
    Journal Article

    Su, H. I.; Stark, S.; Kwan, B.; Boles, S.; Chingos, D.; Ehren, J.; Gorman, J. R.; Krychman, M.; Romero, S. A. D.; Mao, J. J.; more...
    Breast Cancer Research and Treatment (2019)

    Fulltext@MSK | Save
  • A 16-yr follow-up of the European Randomized study of Screening for Prostate Cancer
    Journal Article

    Hugosson, J.; Roobol, M. J.; Månsson, M.; Tammela, T. L. J.; Zappa, M.; Nelen, V.; Kwiatkowski, M.; Lujan, M.; Carlsson, S. V.; Talala, K. M.; more...
    European Urology (2019)

    Fulltext@MSK | Save